Naproxen sodium; sumatriptan succinate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for naproxen sodium; sumatriptan succinate and what is the scope of freedom to operate?
Naproxen sodium; sumatriptan succinate
is the generic ingredient in two branded drugs marketed by Aurobindo Pharma Ltd, Rising, Sun Pharm, and Currax, and is included in four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.Naproxen sodium; sumatriptan succinate has sixteen patent family members in fourteen countries.
Five suppliers are listed for this compound.
Summary for naproxen sodium; sumatriptan succinate
International Patents: | 16 |
US Patents: | 1 |
Tradenames: | 2 |
Applicants: | 4 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 5 |
Clinical Trials: | 11 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for naproxen sodium; sumatriptan succinate |
DailyMed Link: | naproxen sodium; sumatriptan succinate at DailyMed |
Recent Clinical Trials for naproxen sodium; sumatriptan succinate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The Second Affiliated Hospital of Kunming Medical University | Phase 3 |
Second Hospital of Jilin University | Phase 3 |
Beijing Friendship Hospital | Phase 3 |
See all naproxen sodium; sumatriptan succinate clinical trials
Pharmacology for naproxen sodium; sumatriptan succinate
Drug Class | Nonsteroidal Anti-inflammatory Drug Serotonin-1b and Serotonin-1d Receptor Agonist |
Mechanism of Action | Cyclooxygenase Inhibitors Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Paragraph IV (Patent) Challenges for NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
TREXIMET | Tablets | naproxen sodium; sumatriptan succinate | 500 mg/85 mg | 021926 | 1 | 2008-07-23 |
US Patents and Regulatory Information for naproxen sodium; sumatriptan succinate
Expired US Patents for naproxen sodium; sumatriptan succinate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Currax | TREXIMET | naproxen sodium; sumatriptan succinate | TABLET;ORAL | 021926-002 | May 14, 2015 | ⤷ Try a Trial | ⤷ Try a Trial |
Currax | TREXIMET | naproxen sodium; sumatriptan succinate | TABLET;ORAL | 021926-001 | Apr 15, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Currax | TREXIMET | naproxen sodium; sumatriptan succinate | TABLET;ORAL | 021926-001 | Apr 15, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Currax | TREXIMET | naproxen sodium; sumatriptan succinate | TABLET;ORAL | 021926-001 | Apr 15, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Currax | TREXIMET | naproxen sodium; sumatriptan succinate | TABLET;ORAL | 021926-001 | Apr 15, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for naproxen sodium; sumatriptan succinate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2380827 | ⤷ Try a Trial | |
Japan | 2006515856 | ⤷ Try a Trial | |
Canada | 2509023 | FORMES GALENIQUES MULTICOUCHES CONTENANT DES AINS ET DES TRIPTANES (MULTILAYER DOSAGE FORMS CONTAINING NSAIDS AND TRIPTANS) | ⤷ Try a Trial |
Mexico | PA05006954 | FORMAS DE DOSIFICACION DE CAPAS MULTIPLES QUE CONTIENEN NSAIDS Y TRIPTANOS. (Multilayer Dosage Forms Containing NSAIDs and Triptans.) | ⤷ Try a Trial |
Norway | 336458 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for naproxen sodium; sumatriptan succinate
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1411900 | 2011C/016 | Belgium | ⤷ Try a Trial | PRODUCT NAME: NAPROXENE ET ESOMEPRAZOLE (SOUS LA FORME D'ESOMEPRAZOLE MAGNESIUM TRIHYDRATE); AUTHORISATION NUMBER AND DATE: BE382505 20101214 |
1411900 | 2011/016 | Ireland | ⤷ Try a Trial | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE MODIFIED-RELEASE TABLETS; NAT REGISTRATION NO/DATE: PA0970/060/001 20101221; FIRST REGISTRATION NO/DATE: PL17901/0263-0001 20101105 |
0984957 | CR 2012 00035 | Denmark | ⤷ Try a Trial | PRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105 |
1411900 | 1190013-1 | Sweden | ⤷ Try a Trial | PRODUCT NAME: NAPROXEN OCH ESOMEPRAZOL; NAT. REG. NO/DATE: MTNR 43248 20101203; FIRST REG.: GB PL 17901/0263 20101105 |
1411900 | SPC/GB11/015 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.